Funding for this research was provided by:
Received: 5 May 2020
Accepted: 16 September 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all patients before enrolment into the study. The study is being conducted in accordance with the principles established in the Declaration of Helsinki and the International Council for Harmonisation Good Clinical Practice Guideline.
: Not applicable.
: CEB has received grants and consultancy fees from AstraZeneca. CE, GC, AM, CS and KB are employees of AstraZeneca and own stock and stock options in AstraZeneca. JD and JRP are employees of Amgen Inc. and own stock and stock options in Amgen Inc. SD and LC declare that they have no competing interests.